Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

Andrea Chiricozzi; M. V. Cannizzaro; G. A. Salandri; B. Marinari; R. Pitocco; A. Dattola; F. Regine; R. Saraceno; L. Bianchi; S. Chimenti; A. Costanzo

doi:10.1111/jdv.13403

Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

Andrea Chiricozzi^*, M. V. Cannizzaro, G. A. Salandri, B. Marinari, R. Pitocco, A. Dattola, F. Regine, R. Saraceno, L. Bianchi, S. Chimenti, A. Costanzo

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

4 Citazioni (Scopus)

Abstract

Not available

Lingua originale	English
pagine (da-a)	e128-e129
Rivista	Journal of the European Academy of Dermatology and Venereology
Volume	30
DOI	https://doi.org/10.1111/jdv.13403
Stato di pubblicazione	Pubblicato - 2016

Keywords

2708
Adalimumab
Anti-Inflammatory Agents
Humans
Infectious Diseases
Interleukin-17
Psoriasis
Severity of Illness Index
Tears

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1111/jdv.13403

Altri file e collegamenti

Cita questo

Chiricozzi, A., Cannizzaro, M. V., Salandri, G. A., Marinari, B., Pitocco, R., Dattola, A., Regine, F., Saraceno, R., Bianchi, L., Chimenti, S., & Costanzo, A. (2016). Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy. Journal of the European Academy of Dermatology and Venereology, 30, e128-e129. https://doi.org/10.1111/jdv.13403

@article{bb8cc3ab6a83469a863437d65f2a8d93,

title = "Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy",

abstract = "Not available",

keywords = "2708, Adalimumab, Anti-Inflammatory Agents, Humans, Infectious Diseases, Interleukin-17, Psoriasis, Severity of Illness Index, Tears, 2708, Adalimumab, Anti-Inflammatory Agents, Humans, Infectious Diseases, Interleukin-17, Psoriasis, Severity of Illness Index, Tears",

author = "Andrea Chiricozzi and Cannizzaro, {M. V.} and Salandri, {G. A.} and B. Marinari and R. Pitocco and A. Dattola and F. Regine and R. Saraceno and L. Bianchi and S. Chimenti and A. Costanzo",

year = "2016",

doi = "10.1111/jdv.13403",

language = "English",

volume = "30",

pages = "e128--e129",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

Chiricozzi, A, Cannizzaro, MV, Salandri, GA, Marinari, B, Pitocco, R, Dattola, A, Regine, F, Saraceno, R, Bianchi, L, Chimenti, S & Costanzo, A 2016, 'Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy', Journal of the European Academy of Dermatology and Venereology, vol. 30, pagg. e128-e129. https://doi.org/10.1111/jdv.13403

TY - JOUR

T1 - Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

AU - Chiricozzi, Andrea

AU - Cannizzaro, M. V.

AU - Salandri, G. A.

AU - Marinari, B.

AU - Pitocco, R.

AU - Dattola, A.

AU - Regine, F.

AU - Saraceno, R.

AU - Bianchi, L.

AU - Chimenti, S.

AU - Costanzo, A.

PY - 2016

Y1 - 2016

N2 - Not available

AB - Not available

KW - 2708

KW - Adalimumab

KW - Anti-Inflammatory Agents

KW - Humans

KW - Infectious Diseases

KW - Interleukin-17

KW - Psoriasis

KW - Severity of Illness Index

KW - Tears

KW - 2708

KW - Adalimumab

KW - Anti-Inflammatory Agents

KW - Humans

KW - Infectious Diseases

KW - Interleukin-17

KW - Psoriasis

KW - Severity of Illness Index

KW - Tears

UR - http://hdl.handle.net/10807/131655

UR - http://www.wiley.com/bw/journal.asp?ref=0926-9959

U2 - 10.1111/jdv.13403

DO - 10.1111/jdv.13403

M3 - Article

SN - 0926-9959

VL - 30

SP - e128-e129

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo